𝔖 Bobbio Scriptorium

✦ LIBER ✦

EARLY NON-RESPONSE TO ANTIPSYCHOTIC MEDICATIONS IS AN IMPORTANT CLINICAL MARKER OF SUBSEQUENT NON-RESPONSE IN THE TREATMENT OF SCHIZOPHRENIA

✍ Scribed by Bruce Kinon

Book ID: 119556942
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 72 KB
Volume: 102
Category: Article
ISSN: 0920-9964
DOI: 10.1016/s0920-9964(08)70119-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early response to antipsychotic therapy

Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis

✍ Virginia L. Stauffer; Michael Case; Bruce J. Kinon; Robert Conley; Haya Ascher-S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Early symptom response to antipsychotic

Early symptom response to antipsychotic medication as a marker of subsequent symptom change: An eighteen-month follow-up study of recent episode schizophrenia

✍ Stephen Z. Levine; Stefan Leucht 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 671 KB

Difference in early prediction of antips

Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia

✍ Kotaro Hatta; Taro Otachi; Yasuhiko Sudo; Tatsuro Hayakawa; Yuko Ashizawa; Hiros 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Response by Luis Kancyper (A.P.A.) : 2 A

Response by Luis Kancyper (A.P.A.) : 2 Are there elements (excluding aggression or destructiveness) that are exclusively non-sexual or is sexuality the unifying idea in your concept of transference? To what extent do you consider transference as sexual or to what extent are there non-sexual factors (excluding aggression)? Is desire an equivalent of sexuality in your clinical conceptualizations?

📂 Article 📅 2011 🏛 Institute of Psychoanalysis 🌐 English ⚖ 179 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB